Back to Search Start Over

The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth.

Authors :
Franklin A
Salgueiro VC
Layton AJ
Sullivan R
Mize T
Vázquez-Iniesta L
Benedict ST
Gurcha SS
Anso I
Besra GS
Banzhaf M
Lovering AL
Williams SJ
Guerin ME
Scott NE
Prados-Rosales R
Lowe EC
Moynihan PJ
Source :
Nature communications [Nat Commun] 2024 Jul 09; Vol. 15 (1), pp. 5740. Date of Electronic Publication: 2024 Jul 09.
Publication Year :
2024

Abstract

Mycobacterial glycolipids are important cell envelope structures that drive host-pathogen interactions. Arguably, the most important are lipoarabinomannan (LAM) and its precursor, lipomannan (LM), which are trafficked from the bacterium to the host via unknown mechanisms. Arabinomannan is thought to be a capsular derivative of these molecules, lacking a lipid anchor. However, the mechanism by which this material is generated has yet to be elucidated. Here, we describe the identification of a glycoside hydrolase family 76 enzyme that we term LamH (Rv0365c in Mycobacterium tuberculosis) which specifically cleaves α-1,6-mannoside linkages within LM and LAM, driving its export to the capsule releasing its phosphatidyl-myo-inositol mannoside lipid anchor. Unexpectedly, we found that the catalytic activity of this enzyme is important for efficient exit from stationary phase cultures, potentially implicating arabinomannan as a signal for growth phase transition. Finally, we demonstrate that LamH is important for M. tuberculosis survival in macrophages.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
38982040
Full Text :
https://doi.org/10.1038/s41467-024-50051-3